A 27-year-old patient came in with history of swelling in the neck on the right side.
A 27-year-old patient came in with history of swelling in the neck on the right side. Ultrasound scan showed enlarged diffusely hypoechoic right lobe of thyroid with increased vascularity. Left lobe and isthmus were absent. No previous history of hemithyroidectomy. Thyroid function tests showed hyperthyroidism.
Figure 1: Absent left lobe of thyroid and isthmus
Figure 2: Absent left lobe of thyroid and isthmus
Figure 3: Enlarged diffusely hypoechoic right lobe
Figure 4: Right thyroid lobe with increased vascularity
Figure 5: Right thyroid lobe with increased vascularity
Discussion: Hemithyroid agenesis is a rare congenital anomaly of thyroid has found to be three times more common in females as compared to males. In 80 percent, the left thyroid lobe is absent and about 50 percent of patients with left hemithyroid agenesis will also have an absent thyroid isthmus.
Many times, the patient is found to have hemiagenesis of a thyroid lobe incidentally. Coexisting thyroid disorders in the remaining lobe are a common occurrence with hemiagenesis.
Disorders that haven reported in the remnant thyroid lobe include hyperthyroidism, hypothyroidism, multinodular goiter, chronic thyroiditis, adenocarcinoma, and papillary thyroid carcinoma. Hyperthyroidism is the most prevalent disorder associated with thyroid hemiagenesis. In fact, many cases of hemiagenesis discovered upon workup of the hyperthyroidism.
Harpreet Singh, MD, JP Scan private diagnostic center, Khanna, Punjab, India
GE HealthCare Debuts AI-Powered Cardiac CT Device at ACC Conference
April 1st 2025Featuring enhanced low-dose image quality with motion-free images, the Revolution Vibe CT system reportedly facilitates improved diagnostic clarity for patients with conditions ranging from in-stent restenosis to atrial fibrillation.
The Reading Room Podcast: Current Perspectives on the Updated Appropriate Use Criteria for Brain PET
March 18th 2025In a new podcast, Satoshi Minoshima, M.D., Ph.D., and James Williams, Ph.D., share their insights on the recently updated appropriate use criteria for amyloid PET and tau PET in patients with mild cognitive impairment.